BCAT

A year ago, the Guggenheim Strategic Opportunity fund (GOF) was on top of the CEF world, trading at a 30% market price premium over its NAV. But there was another equity/fixed-income CEF coming up on its heels and once the BlackRock Capital Allocation fund (BCAT) got a 124% distribution raise in 2024, it was off to-the-races. The result has been one of the most diverging fortunes for both funds that I have ever seen in CEFs.

BlackRock Capital Allocation Term Trust remains a hold, with its high yield supported by recent tech-driven rallies but unsustainable over the long term. BCAT's option writing and concentrated portfolio have fueled outperformance, but these strategies cap long-term growth and risk NAV erosion as payouts exceed earnings. Current distributions are largely return of capital, with 91% YTD, signaling NAV drawdown and limited sustainability if market momentum fades or interest rates rise.

NEW YORK--(BUSINESS WIRE)--BlackRock Provides Update on Closed-End Fund Discount Management Programs.

The BlackRock Capital Allocation Term Trust (BCAT) offers a nearly 20% managed distribution rate, but that payout creates real pressure on NAV unless portfolio returns remain strong. The fund is higher quality than many ultra-high-yield peers because it is diversified, unlevered, and not built around a single-stock option strategy. The main concern is not ROC classification alone, but the combination of heavy ROC, weak price appreciation, recurring payout step-downs, and NAV erosion.